Travere Therapeutics, Inc. (NASDAQ:TVTX) has 270 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -231,109 | -2.85% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | -88,494 | -0.83% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | -242,236 | -17.09% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -148,240 | -28.63% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 6,723,715 | 232.32% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -85,078 | -7.89% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 5,129 | 3,309.03% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -304,139 | -4.60% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -149,770 | -21.88% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,538,827 | 47.82% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | -449,028 | -46.42% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 483,565 | 12.74% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -431,843 | -45.47% | $0.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Dec, 2025 | 0 | 3,773,564 | 0.00% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -70,454 | -14.29% | $0.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 0 | -2,960,109 | -44.02% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -165,776 | -28.98% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | -625,000 | -17.60% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 205,181 | 179.23% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 494,665 | 28.23% | $0.00 |